HAE - Haemonetics Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
85.14
-1.55 (-1.79%)
At close: 3:59PM EDT

85.09 -0.05 (-0.06%)
After hours: 4:10PM EDT

Stock chart is not supported by your current browser
Previous Close 86.75
Open 87.00
Bid 85.05 x 1000
Ask 85.06 x 1000
Day's Range 84.34 - 86.71
52 Week Range 70.86 - 117.56
Volume 350,212
Avg. Volume 469,231
Market Cap 4.343B
Beta (3Y Monthly) 0.78
PE Ratio (TTM) 99.00
EPS (TTM) N/A
Earnings Date N/A
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A
Trade prices are not sourced from all markets
  • Markit 6 days ago

    See what the IHS Markit Score report has to say about Haemonetics Corp.

    Haemonetics Corp NYSE:HAEView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for HAE with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding HAE are favorable, with net inflows of $3.79 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Haemonetics' Plasma Unit Grows, Global Expansion on Track
    Zacks 6 days ago

    Haemonetics' Plasma Unit Grows, Global Expansion on Track

    Haemonetics' (HAE) Plasma arm steadily witnesses solid growth in the fiscal third quarter on 16% revenue rise at constant currency.

  • Why Is Haemonetics (HAE) Down 1.4% Since Last Earnings Report?
    Zacks 11 days ago

    Why Is Haemonetics (HAE) Down 1.4% Since Last Earnings Report?

    Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • American City Business Journals last month

    Medidata Solutions quadrupling local presence, could hire hundreds

    Medidata Solutions acquired Waltham-based Shyft Analytics in June, and plans to hire hundreds of employees with a move to downtown Boston.

  • Thomson Reuters StreetEvents last month

    Edited Transcript of HAE earnings conference call or presentation 5-Feb-19 1:00pm GMT

    Q3 2019 Haemonetics Corp Earnings Call

  • Haemonetics (HAE) Earnings Top, Revenues Lag Estimates in Q3
    Zacks last month

    Haemonetics (HAE) Earnings Top, Revenues Lag Estimates in Q3

    Haemonetics' (HAE) year-over-year earnings growth in Q3 is backed by benefits from complexity reduction and investments along with strength in market demand and success from early launches.

  • Haemonetics Corp (HAE) Q3 2019 Earnings Conference Call Transcript
    Motley Fool last month

    Haemonetics Corp (HAE) Q3 2019 Earnings Conference Call Transcript

    HAE earnings call for the period ending December 29, 2018.

  • Haemonetics (HAE) Q3 Earnings Surpass Estimates
    Zacks last month

    Haemonetics (HAE) Q3 Earnings Surpass Estimates

    Haemonetics (HAE) delivered earnings and revenue surprises of 6.78% and -1.14%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press last month

    Haemonetics: Fiscal 3Q Earnings Snapshot

    On a per-share basis, the Braintree, Massachusetts-based company said it had net income of 35 cents. Earnings, adjusted for non-recurring costs and amortization costs, were 63 cents per share. The results ...

  • Why We’re Not Impressed By Haemonetics Corporation’s (NYSE:HAE) 8.3% ROCE
    Simply Wall St. 2 months ago

    Why We’re Not Impressed By Haemonetics Corporation’s (NYSE:HAE) 8.3% ROCE

    Today we are going to look at Haemonetics Corporation (NYSE:HAE) to see whether it might be an attractive investment prospect. Specifically, we're going to calculate its Return On Capital Employed Read More...

  • Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for
    Zacks 2 months ago

    Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for

    Haemonetics (HAE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Perrigo Stock Up as Appeal Date for Irish Tax Bill Nears
    Zacks 3 months ago

    Perrigo Stock Up as Appeal Date for Irish Tax Bill Nears

    Perrigo's (PRGO) shares rebound as the time to file an appeal against the Irish tax bill of $1.9 billion nears its deadline of Dec 28.

  • What Investors Should Know About Haemonetics Corporation’s (NYSE:HAE) Financial Strength
    Simply Wall St. 3 months ago

    What Investors Should Know About Haemonetics Corporation’s (NYSE:HAE) Financial Strength

    Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Haemonetics Corporation (NYSE:HAE) with a market-capitalization of US$4.8b, rarely draw their attention. However, generally ignored mid-caps have Read More...

  • Perrigo Plunges on $1.9B Tax Bill From Irish Government
    Zacks 3 months ago

    Perrigo Plunges on $1.9B Tax Bill From Irish Government

    Perrigo (PRGO), in a SEC filing, reports a $1.9 billion tax bill from Irish revenue department related to its subsidiary, Elan Pharma.

  • Haemonetics to move HQ to Financial District, taking DraftKings space
    American City Business Journals 3 months ago

    Haemonetics to move HQ to Financial District, taking DraftKings space

    Haemonetics Corp., a Braintree-based company that makes blood management devices and software, has announced plans to move its headquarters to Boston's Financial District in 2019. Haemonetics (NYSE: HAE) said Wednesday it has signed a 14-year lease for 62,000 square feet of space at 125 Summer St. Part of that space — around 20,000 square feet — is currently occupied by online fantasy sports company DraftKings Inc., which is moving its headquarters to 500 Boylston St./222 Berkeley St. in Back Bay. More than 200 Haemonetics employees will relocate to the new Boston office, the company said.

  • Here's Why You Should Buy Haemonetics (HAE) Stock Right Now
    Zacks 3 months ago

    Here's Why You Should Buy Haemonetics (HAE) Stock Right Now

    Haemonetics (HAE) continues to witness strong growth in Plasma franchise.

  • Is Haemonetics Corporation (HAE) Going to Burn These Hedge Funds?
    Insider Monkey 3 months ago

    Is Haemonetics Corporation (HAE) Going to Burn These Hedge Funds?

    Is Haemonetics Corporation (NYSE:HAE) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from industry insiders. They sometimes fail miserably but historically their consensus stock picks outperformed the market after […]

  • Haemonetics (HAE) Down 8.9% Since Last Earnings Report: Can It Rebound?
    Zacks 3 months ago

    Haemonetics (HAE) Down 8.9% Since Last Earnings Report: Can It Rebound?

    Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Should iShares Morningstar Small-Cap ETF (JKJ) Be on Your Investing Radar?
    Zacks 4 months ago

    Should iShares Morningstar Small-Cap ETF (JKJ) Be on Your Investing Radar?

    Style Box ETF report for JKJ